Provided by Tiger Fintech (Singapore) Pte. Ltd.

Day One Biopharmaceuticals Inc.

6.79
-0.4000-5.56%
Post-market: 6.790.00000.00%17:47 EDT
Volume:1.15M
Turnover:7.96M
Market Cap:688.25M
PE:-9.56
High:7.13
Open:7.10
Low:6.78
Close:7.19
Loading ...
Nov 29, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 29, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Aug 18, 2021

Statement Of Changes In Beneficial Ownership

3 - Initial statement of beneficial ownership of securities
Aug 18, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Aug 17, 2021

Major Issues Report

8-K - Current report
Aug 10, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 10, 2021

Major Issues Report

8-K - Current report
Jun 10, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Jun 09, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Jun 07, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
May 27, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
May 26, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
May 24, 2021

Correspondence

CORRESP [Cover] - Correspondence
May 24, 2021

Correspondence

CORRESP [Cover] - Correspondence
May 24, 2021

Correspondence

CORRESP [Cover] - Correspondence
May 24, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
May 04, 2021

Correspondence

CORRESP [Cover] - Correspondence
May 04, 2021

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933